SECOND-LINE CHEMOTHERAPY WITH FLUOROURACIL, LEUCOVORIN, AND IRINOTECAN (FOLFIRI REGIMEN) IN PATIENTS WITH ADVANCED SMALL BOWEL ADENOCARCINOMA AFTER FAILURE OF FIRST-LINE PLATINUM-BASED CHEMOTHERAPY: A MULTICENTER AGEO STUDY

被引：0
|
作者：
Aparicio, T. [1 ]
Zaanan, A. [2 ]
Gauthier, M. [3 ]
Malka, D. [4 ]
Locher, C. [5 ]
Gornet, J. [6 ]
Thirot-Bidault, A. [7 ]
Tougeron, D. [8 ]
Taieb, J. [9 ]
Bonnetain, F. [3 ]
机构：
[1] Univ Paris 13, Hop Avicenne, AP HP, Bobigny, France
[2] Univ Paris 06, Hop St Antoine, AP HP, Paris, France
[3] Ctr Georges Francois Leclerc, Unite Biostat & Epidemiol, Dijon, France
[4] Inst Gustave Roussy, Villejuif, France
[5] Ctr Hosp Meaux, Meaux, France
[6] Hop St Louis, AP HP, Paris, France
[7] Hop Kremlin Bicetre, AP HP, Le Kremlin Bicetre, France
[8] Hop Charles Nicolle, Rouen, France
[9] Hop Europeen Georges Pompidou, APHP, Paris, France
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [1] Second-Line Chemotherapy With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI Regimen) in Patients With Advanced Small Bowel Adenocarcinoma After Failure of First-Line Platinum-Based Chemotherapy A Multicenter AGEO Study
    Zaanan, Aziz
    Gauthier, Melanie
    Malka, David
    Locher, Christophe
    Gornet, Jean-Marc
    Thirot-Bidault, Anne
    Tougeron, David
    Taieb, Julien
    Bonnetain, Franck
    Aparicio, Thomas
    CANCER, 2011, 117 (07) : 1422 - 1428
  • [2] Second-line chemotherapy by FOLFIRI in patients with advanced small bowel adenocarcinoma A multicenter AGEO study
    Zaanan, A.
    Gauthier, M.
    Malka, D.
    Locher, C.
    Gornet, J.
    Thirot-Bidault, A.
    Tougeron, D.
    Taieb, J.
    Bonnetain, F.
    Aparicio, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy
    Mayerhofer, K
    Kucera, E
    Zeisler, H
    Speiser, P
    Reinthaller, A
    Sevelda, P
    GYNECOLOGIC ONCOLOGY, 1997, 64 (01) : 109 - 113
  • [4] PROSPECTIVE OBSERVATIONAL COHORT STUDY OF SECOND-LINE CHEMOTHERAPY ADMINISTRATION AFTER FIRST-LINE PLATINUM-BASED CHEMOTHERAPY FOR PATIENTS WITH ADVANCED NSCLC IN JAPAN (SAPPHIRE STUDY)
    Goto, Yasushi
    Yoh, Kiyotaka
    Kishi, Kazuma
    Ohashi, Yasuo
    Kunitoh, Hideo
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S869 - S870
  • [5] Prospective observational cohort study of second-line chemotherapy administration after first-line platinum-based chemotherapy for patients with advanced NSCLC in Japan (SAPPHIRE study)
    Yoh, Kiyotaka
    Goto, Yasushi
    Naito, Yoichi
    Kishi, Kazuma
    Ohashi, Yasuo
    Kunitoh, Hideo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] RANDOMIZED PHASE II STUDY OF BELOTECAN OR TOPOTECAN CHEMOTHERAPY AS SECOND-LINE CHEMOTHERAPY AFTER PLATINUM-BASED FIRST-LINE CHEMOTHERAPY FOR SMALL CELL LUNG CANCER
    Yoon, S.
    Lee, D. H.
    Choi, C.
    Lee, J. C.
    Lee, J. S.
    Kim, S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [7] Second-line treatment options in advanced thymic carcinoma after failure of platinum-based chemotherapy: A multicenter retrospective study
    Wang, Yang
    Zhang, Xuanye
    Tian, Dan
    Han, Sen
    Zhang, Jie
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Chen, Xiaoling
    Ma, Xiangjuan
    Tian, Guangming
    Wu, Di
    Zhang, Ziran
    Long, Jieran
    Fang, Jian
    CANCER MEDICINE, 2023, 12 (03): : 2303 - 2311
  • [8] A randomized trial of FOLFIRI versus docetaxel and cisplatin as a second-line chemotherapy after failure of first-line chemotherapy in advanced gastric cancer
    Kil, Lee Sang
    Seok, Moon Hee
    Eun, Kim Sung
    Seok, Jang Jin
    Young, Cho Joo
    Sun, Kim Eun
    Hyung, Lee Si
    Chul, Park Jun
    Kang, Lee Yong
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] Efficacy and toxicity of second-line chemotherapy in patients with advanced oesophageal squamous cell carcinoma progressing after a first line of 5-fluorouracil and platinum-based therapy: An AGEO retrospective multicentric study
    Auzolle, C.
    Dubreuil, O.
    Pozet, A.
    Coriat, R.
    Dhooge, M.
    Ducreux, M.
    Mons, M.
    Brieau, B.
    Baumgaertner, I.
    Gornet, J. M.
    Lievre, A.
    Locher, C.
    Mary, F.
    Bonnetain, F.
    Landi, B.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S438 - S438
  • [10] Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study
    Jeeyun Lee
    Kyung Hae Jung
    Young Suk Park
    Joong Bae Ahn
    Sang Jun Shin
    Seock-Ah Im
    Do Youn Oh
    Dong Bok Shin
    Tae Won Kim
    Namsu Lee
    Jae Ho Byun
    Yong Sang Hong
    Joon Oh Park
    Se Hoon Park
    Ho Yeong Lim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 657 - 663
12345